HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulationMaria Serena Roca, Alfredo Budillon|Journal of Experimental & Clinical Cancer Research|2022Cited by 42